| Abbey Goodman |
Abbey Goodman is currently the Chief Commercial Officer-US Region at Profound Medical Corp. She obtained an undergraduate degree from Louisiana State University. |
| Mathieu Burtnyk |
Mathieu Burtnyk is currently the Chief Operating Officer at Profound Medical Corp. He holds a doctorate degree from the University of Toronto. |
| Rashed Dewan |
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp. He started this position in 2022. Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California. |
| Hartmut Warnken |
Hartmut Warnken is currently the Chief Commercial Officer-OUS at Profound Medical Corp. He previously worked as the Director-Intra Operative Operating Room Solutions at BrainLAB, Inc. and as the Managing Director at Imris Pte Ltd., Imris Germany GmbH, and Imris KK. Mr. Warnken received a graduate degree from Augsburg College and undergraduate, graduate, and MBA degrees from ESCP Europe Campus London. |
| Arun S. Menawat |
Arun S. Menawat is currently the Chairman & Chief Executive Officer at Profound Medical Corp., Vice Chairman at Ontario Bioscience Industry Organization, Chairman at Firefly Neuroscience Ltd., Independent Director at Stereotaxis, Inc., and Advisor at Baylis Medical Co., Inc. and Amplitude Ventures. Previously, he served as the Chairman, President & Chief Executive Officer at Novadaq Technologies, Inc., Chief Executive Officer & Director at Profound Medical, Inc., President, Chief Operating Officer & Director at Cedara Software Corp., and Director at Spartan Bioscience, Inc. He also held positions as a Director at MedCurrent Corp., Manager-Research & Development at Hercules, Inc., and Vice President-Operations at Tenneco, Inc. Dr. Menawat obtained his undergraduate degree from the University of the District of Columbia, a doctorate from the University of Maryland in 1982, and an MBA from Kellogg School of Management in 1996. |
| Kris Shaw |
Kris Shaw is the founder of OME Group, Inc. (founded in 1991) and Baylis Medical Co., Inc. (founded in 1989). Mr. Shaw's current job(s) include being a Director at Intellijoint Surgical, Inc., an Independent Director at Profound Medical Corp., a Director at AdvaMed Accel, and the President at Baylis Medical Technologies, Inc. Mr. Shaw's former job(s) include being a Director at Venture Labs, Inc., MEDEC, Conavi Medical, Inc., and NovoEd, Inc. Mr. Shaw's education history includes an undergraduate degree from The University of Waterloo. |
| Jean-François Pariseau |
Founder of Amplitude Ventures, Jean-François Pariseau is Partner at this company and Partner at BDC Venture Capital. He is also on the board of 5 other companies.
In the past Mr. Pariseau occupied the position of Director at Imagia Cybernetics, Inc., Partner-Healthcare Fund at BDC Capital, Inc., Investment Manager at CDP Capital Technology Ventures and Investment Manager at CDP Capital Private Equity.
He received an undergraduate degree from the University of Sherbrooke, a graduate degree from the University of Montréal and an MBA from HEC Montréal. |
| Brian Robert Ellacott |
Brian Robert Ellacott's current jobs include being the Chief Executive Officer & Director at Belmont Instrument LLC since 2017, the Chief Executive Officer & Director at Belmont Medical Technologies Ltd. since 2018, a Director at Aspen Surgical Products, Inc., and an Independent Director at Profound Medical Corp. since 2018. Mr. Ellacott's former jobs include being the President & Chief Executive Officer at 2941881 Canada, Inc. from 2013 to 2017, the Chairman at Canadian Assistive Devices Association from 2007 to 2010, a Director at Mediwatch Ltd., and the Executive Vice President & General Manager at Invacare Corp. from 2004 to 2005. Mr. Ellacott's education history includes completing an undergraduate degree at Wilfrid Laurier University. |
| Arthur L. Rosenthal |
Arthur L. Rosenthal founded Geyecue Medical Systems Ltd. in 2011, where he is working as Chief Executive Officer from 2011 and EyeCue, Inc. in 2011, where he worked as Chief Executive Officer from 2011 to 2015. Dr. Rosenthal also currently works at Arch Biosurgery, Inc., as Chairman from 2011, Interface Biologics, Inc., as Chairman from 2011, Profound Medical Corp., as Independent Director from 2018, and Boston University College of Engineering, as Professor from 2010. Dr. Rosenthal also formerly worked at Cappella, Inc., as President & Chief Executive Officer from 2009 to 2011, Labcoat Ltd., as Chairman & Chief Executive Officer from 2005 to 2008, ArraVasc Ltd., as Executive Vice Chairman from 2011 to 2012, LivaNova USA, Inc., as Independent Non-Executive Director in 2015, HydroCision, Inc., as Director, Ultimate Finance Holdings Ltd., as Non-Executive Director from 2000 to 2010, Tornado Medical Systems, Inc., as Director from 2011 to 2012, Renovo Ltd., as Non-Executive Director from 2000 to 2010, Arch Therapeutics, Inc., as Director, Arch Therapeutics, Inc., as Independent Director from 2011 to 2015, LivaNova Plc, as Independent Director from 2015 to 2022, Arch Technologies, Inc., as Non-Executive Director from 2013 to 2015, Advent International LP, as Venture Advisor from 2005 to 2007, C. R. Bard, Inc. (New Jersey), as Vice President-Research & Development, Boston Scientific Corp., as Chief Scientific Officer & Senior Vice President from 1994 to 2005, Davol, Inc., as Vice President from 1982 to 1991, Pfizer Ltd., as Chief Scientific Officer, and Johnson & Johnson Medical, Inc., as Vice President-Research & Development. Dr. Rosenthal received his undergraduate degree from the University of Connecticut and doctorate degree in 1973 from the University of Massachusetts. |
